Literature DB >> 9236836

p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.

V A Holst1, S Finkelstein, T V Colby, J L Myers, S A Yousem.   

Abstract

In an attempt to understand the molecular pathogenesis of biphasic pulmonary neoplasms, the authors studied 25 cases of carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma using a combined immunohistochemical and topographic genotyping approach for the presence of p53 abnormalities within the different epithelial and mesenchymal components of these tumors. Genotyping involved a search for point mutational damage in p53 exons 5-8, which was correlated with p53 immunoreactivity. This analytical approach demonstrated p53 missense point mutations in four of nine cases of spindle cell carcinoma with a 100% concordance rate between p53 immunopositivity and the presence of DNA mutational damage. One of six carcinosarcomas, heterologous in type, exhibited a p53 mutation. The concordance rate among carcinosarcomas was also 100%. However, the concordance rate among classic biphasic pulmonary blastomas was only 43%, with one of seven cases demonstrating a p53 mutation by DNA genotyping. The lack of concordance in pulmonary blastomas was possibly due to the existence of genotypically distinct subsets of tumor cells likely bearing mutations among largely nonmutated cells. In a similar fashion, among three well-differentiated fetal type adenocarcinomas, no p53 mutations were detected despite the presence of focal p53 immunopositivity in one of the cases. No K-ras mutations were detected in any of the 25 tumors examined. Monoclonal histogenesis from a single totipotential cell in a subset of these neoplasms (six of 22 cases) was supported by the finding of p53 overexpression and identical p53 mutational genotype in both the epithelial and spindle elements of the tumors. Furthermore, the finding of a small percentage of p53-positive tumor cells within one or both components suggests late acquisition of p53 mutational change in a subset of pulmonary blastomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236836     DOI: 10.1097/00000478-199707000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Sarcomatoid carcinomas of the lung--are these histogenetically heterogeneous tumors?

Authors:  Markus Blaukovitsch; Iris Halbwedl; Hannelore Kothmaier; Margit Gogg-Kammerer; Helmut H Popper
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

2.  Expression of CD99 in pleomorphic carcinomas of the lung.

Authors:  Seong-Ho Yoo; Jungho Han; Tae Jin Kim; Doo Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

3.  Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.

Authors:  T Hashimoto; Y Tokuchi; M Hayashi; Y Kobayashi; K Nishida; S Hayashi; Y Ishikawa; K Nakagawa; J Hayashi; E Tsuchiya
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Immunohistochemical analysis of NANOG expression and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma.

Authors:  Takeshi Tamaki; Toshiki Shimizu; Maiko Niki; Michiomi Shimizu; Tohru Nishizawa; Shosaku Nomura
Journal:  Oncol Lett       Date:  2017-03-16       Impact factor: 2.967

5.  Pulmonary carcinosarcoma initially presenting as invasive aspergillosis: a case report of previously unreported combination.

Authors:  Ariyo O Olobatoke; Doina David; Wasif Hafeez; Thien Van; Husain A Saleh
Journal:  Diagn Pathol       Date:  2010-01-29       Impact factor: 2.644

6.  Genetic profile of gliosarcomas.

Authors:  R M Reis; D Könü-Lebleblicioglu; J M Lopes; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.

Authors:  H Kanazawa; M Ebina; N Ino-Oka; M Shimizukawa; T Takahashi; S Fujimura; T Imai; T Nukiwa
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

8.  Pulmonary carcinosarcoma successfully resected using the rib-cross thoracotomy approach: report of a case.

Authors:  Noriaki Sakakura; Tatsuo Uchida; Yuka Kitamura; Motokazu Suyama
Journal:  Surg Today       Date:  2012-10-12       Impact factor: 2.549

9.  Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins.

Authors:  Rani Kanthan; Jenna-Lynn B Senger; Dana Diudea
Journal:  World J Surg Oncol       Date:  2010-07-19       Impact factor: 2.754

10.  Expression of KIT (CD117) in biphasic pulmonary blastoma. Novel data on histogenesis.

Authors:  T Hansen; F Bittinger; C Kortsik; B Wagner; C J Kirkpatrick
Journal:  Lung       Date:  2003       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.